Vivanza Biosci.

Vivanza_Biosci.03 May 2024

Trading

₹

-0.04 (-0.52%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Vivanza Biosci.

Vivanza Biosci.

Trading

Vivanza_Biosci.03 May 2024

₹

-0.04 (-0.52%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
24-Jan-2023	S	Board the Board considered the proposal for sub-division of 1 (One) equity share of the Company having face value of Rs. 10/- each into 10 (Ten) equity shares having face value of Rs. 1/- each, subject to regulatory/statutory approvals as may be required and the approval of the members of the Company. Further, the Board recommended consequential amendments in the Capital Clause of the Memorandum of Association of the Company, subject to approval of the members of the Company. Scrutinizer''s Report for sub-division of one (1) Equity Share having face value of Rs.10/- (Rupees Ten) each into 10 (Ten) Equity Shares of nominal value of Rs. 1/- each in the Share Capital of the Company (As Per BSE Announcement Dated on 25/02/2023) Board of Directors of the Company at its meeting held today i.e. Saturday, March 04, 2023 at Registered Office of the Company has inter alia considered and approved the Friday, March 24, 2023 Record Date for the purpose of determining eligibility of shareholders for the purpose of subdivision of one (1) Equity Share having face value of Rs.10/- (Rupees Ten) each into 10 (Ten) Equity Shares of nominal value of Rs. 1/- each in the Share Capital of the Company. (As per BSE Announcement Dated on 04/03/2023) Trading Members of the Exchange are hereby informed that Vivanza Biosciences Limited., has fixed Record Date for the purpose of Sub-Division of the Equity Shares of the Company:- DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE Vivanza Biosciences Limited (530057) RECORD DATE 24.03.2023 PURPOSE Subdivision of existing the Equity Shares from One Equity Share of Rs.10/- each into Ten Equity Shares of Re.1/- each. SUB-DIVIDED PAID-UP VALUE Re.1/- SUB-DIVIDED PAID-UP VALUE W.E.F. 24/03/2023 DR-746/2022-2023 Note:- i. ISIN No. INE984E01027 of Rs.10/- paid up will not be valid for transactions done on the Exchange on or after 24/03/2023. ii. The new ISIN Number for Re.1/- paid up will be informed to the market by a separate notice. (As Per BSE Notice Dated on 08.03.2023) In Continuation of Notice No. 20230308-20 dated March 08, 2023, Trading Members of the Exchange are hereby informed that the New ISIN number for the Sub-Divided Equity Shares of the Company will be as under: - Company Name & Scrip Code Vivanza Biosciences Limited (530057) New ISIN No. INE984E01035 Remarks Sub-division of Equity Shares from Rs.10/- to Re.1/- The new ISIN number given above, for Equity Shares of Re.1/- each of the Company shall be effective for trades done on and from the Ex-Date i.e. 24-03-2023 (DR-746/2022-2023) (As Per BSE Notice Dated on 20.03.2023)	24-Mar-2023
19-Apr-2024	BC	Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2024 inter alia to consider and approve (i) Audited results for the quarter and	30-Apr-2024
30-Apr-2024	BC	Results for Quarter & financial year ended on 31st March, 2024 Regulation 30_ Announcement for Appointment & Resignation of Independent Director	30-Apr-2024
10-Apr-2024	BC	Ardent Ventures LLP (Sale Dated on: 08/04/2024 & 09/04/2024)	08-Apr-2024
29-Feb-2024	BC	Hemant A Parikh	28-Feb-2024
29-Feb-2024	BC	Hemant A Parikh	27-Feb-2024

No Rights has been declared by Vivanza_Biosci.

Book Closure

Record Date	Split Date	Purpose
30-Apr-2024	-	Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2024 inter alia to consider and approve (i) Audited results for the quarter and
30-Apr-2024	-	Results for Quarter & financial year ended on 31st March, 2024 Regulation 30_ Announcement for Appointment & Resignation of Independent Director
08-Apr-2024	-	Ardent Ventures LLP (Sale Dated on: 08/04/2024 & 09/04/2024)
28-Feb-2024	-	Hemant A Parikh
27-Feb-2024	-	Hemant A Parikh

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Vivanza Biosciences Ltd ₹7.65(-0.04/-0.52%)	7.65	-0.04	30.60	-50.10	95.63	6.48
Computer Point Ltd ₹5.09(+0.12/2.41%)	5.09	+0.12	15.27	116.60	0.00	0.46
Ambalal Sarabhai Enterprises Ltd ₹45.47(-0.68/-1.47%)	45.47	-0.68	348.45	102.27	0.00	9.57
Novartis India Ltd ₹1,057.25(+18.10/1.74%)	1,057.25	+18.10	2,610.43	77.90	27.33	3.72
Aegis Logistics Ltd ₹629.30(-14.10/-2.19%)	629.30	-14.10	22,088.43	60.91	50.06	9.95
Modella Woollens Ltd ₹74.01(+2.01/2.79%)	74.01	+2.01	6.73	0.76	0.00	-73.29

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Gross Sales	2.30	3.37	3.87	4.88	6.02	4.80
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	2.30	3.37	3.87	4.88	6.02	4.80
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	-0.03	0.02	0.05	0.01	0.12	0.01
Total Income	2.27	3.38	3.92	4.89	6.14	4.81
Total Expenditure	2.43	3.10	3.63	4.45	5.97	4.28
PBIDT	-0.16	0.28	0.30	0.44	0.17	0.53
Interest	0.09	0.10	0.11	0.11	0.10	0.11
PBDT	-0.26	0.18	0.19	0.33	0.06	0.42
Depreciation	0.01	0.00	0.00	0.00	0.00	0.00
Tax	0.11	0.00	0.00	0.00	0.12	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	-0.38	0.18	0.19	0.33	-0.05	0.42
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-0.38	0.18	0.19	0.33	-0.05	0.42

EPS (Unit Curr.)	-0.09	0.05	0.05	0.08	-0.14	1.04
EPS (Adj) (Unit Curr.)	-0.09	0.05	0.05	0.08	-0.14	0.10
Calculated EPS (Unit Curr.)	-0.09	0.05	0.05	0.08	-0.01	1.04
Calculated EPS (Adj) (Unit Curr.)	-0.09	0.05	0.05	0.08	-0.01	0.10
Calculated EPS (Ann.) (Unit Curr.)	-0.38	0.18	0.19	0.33	-0.05	4.17
Calculated EPS (Adj) (Ann.) (Unit Curr.)	-0.38	0.18	0.19	0.33	-0.05	0.42
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	4.00	4.00	4.00	4.00	4.00	4.00
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	1.00	1.00	1.00	1.00	1.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	-6.96	8.31	7.75	9.02	2.82	11.04
PBDTM(%)	-11.30	5.34	4.91	6.76	1.00	8.75
PATM(%)	-16.52	5.34	4.91	6.76	-0.83	8.75

Column	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Gross Sales	4.42	6.56	7.62	9.23	8.24	5.86
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	4.42	6.56	7.62	9.23	8.24	5.86
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	-0.03	0.02	0.05	0.01	0.12	0.01
Total Income	4.39	6.58	7.67	9.24	8.36	5.87
Total Expenditure	4.56	6.27	7.30	8.64	8.24	5.30
PBIDT	-0.16	0.31	0.37	0.61	0.12	0.57
Interest	0.09	0.10	0.11	0.11	0.11	0.11
PBDT	-0.26	0.21	0.26	0.49	0.02	0.46
Depreciation	0.01	0.00	0.00	0.00	0.00	0.00
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.15	0.00	0.00	0.00	0.12	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	-0.41	0.21	0.26	0.49	-0.10	0.46
Minority Interest After NP	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit after Minority Interest	-0.41	0.21	0.26	0.49	-0.10	0.46

Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-0.41	0.21	0.26	0.49	-0.10	0.46

EPS (Unit Curr.)	-0.10	0.05	0.07	0.12	-0.26	1.15
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	4.00	4.00	4.00	4.00	4.00	4.00

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	-3.62	4.73	4.86	6.61	1.46	9.73
PBDTM(%)	-5.88	3.20	3.41	5.31	0.24	7.85
PATM(%)	-9.28	3.20	3.41	5.31	-1.21	7.85

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	4.00	4.00	4.00	4.00	4.00	4.00
Reserves Total	0.40	-0.17	-0.63	-0.73	-0.53	-0.08
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	4.40	3.83	3.37	3.27	3.47	3.92
Secured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Unsecured Loans	6.56	4.42	0.18	0.18	0.90	0.77
Total Debt	6.56	4.42	0.18	0.18	0.90	0.77
Total Liabilities	10.96	8.25	3.55	3.45	4.37	4.69
APPLICATION OF FUNDS :
Gross Block	0.02	0.02	0.02	0.00	0.00	0.00
Less : Accumulated Depreciation	0.02	0.02	0.01	0.00	0.00	0.00
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	0.00	0.00	0.01	0.00	0.00	0.00
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	1.91	1.91	1.91	1.91	1.91	1.91
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	1.61	2.23	0.40	0.85	1.91	2.28
Sundry Debtors	12.18	7.35	6.11	6.41	5.54	5.07
Cash and Bank	0.10	0.02	-3.11	-2.81	-3.03	-3.02
Loans and Advances	4.03	2.10	2.02	5.32	3.90	2.81
Total Current Assets	17.93	11.70	5.41	9.77	8.32	7.15
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	9.33	5.93	4.34	8.80	6.41	4.93
Provisions	0.15	0.03	0.05	0.03	0.05	0.05
Total Current Liabilities	9.48	5.96	4.39	8.84	6.46	4.97
Net Current Assets	8.45	5.74	1.02	0.93	1.86	2.18
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.00	0.00
Net Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Total Assets	10.36	7.65	2.94	2.84	3.77	4.09
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	4.00	4.00	4.00	4.00	4.00	4.00
Reserves Total	0.09	-0.51	-0.84	-0.92	-0.71	-0.27
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	4.09	3.49	3.16	3.08	3.29	3.73
Minority Interest	0.00	0.00	0.00	0.00	0.00	0.00
Secured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Unsecured Loans	8.00	5.51	0.36	0.39	1.48	1.32
Total Debt	8.00	5.51	0.36	0.39	1.48	1.32
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities	12.09	9.00	3.52	3.47	4.77	5.05
APPLICATION OF FUNDS :
Gross Block	2.52	2.52	2.52	2.50	2.50	2.50
Less: Accumulated Depreciation	0.21	0.20	0.20	0.19	0.19	0.19
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	2.31	2.32	2.32	2.31	2.31	2.31
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	2.47	2.43	0.65	0.97	2.00	2.28
Sundry Debtors	12.48	7.84	6.25	6.54	5.70	5.07
Cash and Bank	0.14	0.06	-3.09	-2.78	-3.00	-2.97
Loans and Advances	4.46	2.13	1.20	4.41	2.95	2.70
Total Current Assets	19.56	12.45	5.02	9.14	7.65	7.09
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	10.23	6.52	4.86	8.85	6.27	5.05
Provisions	0.16	0.04	0.07	0.04	0.06	0.06
Total Current Liabilities	10.39	6.56	4.93	8.89	6.33	5.10
Net Current Assets	9.17	5.89	0.08	0.25	1.32	1.98
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.00	0.00
Net Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	0.60	0.79	1.11	0.90	1.14	0.75
Total Assets
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.02	0.05	-2.81	-3.03	-3.02
Net Cash from Operating Activities	0.16	-0.68	-3.08	2.80	1.37
Net Cash Used In Investing Activities	0.00	0.00	-0.02	0.00	0.00
Net Cash Used In Financing Activities	-0.08	0.65	2.80	-2.58	-1.38
Net Inc./Dec In Cash And Cash Equivalents	0.09	-0.03	-0.30	0.22	-0.01
Cash And Cash Equivalents At End Of The Year	0.10	0.02	-3.11	-2.81	-3.03

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

43.24%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

56.76%

**Promoter pledged shareholding 43.24%

About Vivanza Biosciences Ltd

Vivanza Biosciences Ltd is in the Trading sector, having a market capitalization of Rs. 30.6 crores. It has reported a sales of Rs. 2.3 crores and a net profit of Rs. -0.38 crores for the quarter ended December 2018. The company management includes , Hemant Parikh,Sunil Shah,Avinash G. Bhojwani,Apeksha Vyas,Jayendra Mehta (Vivanza Biosciences Ltd) among others.

Chairman

Registered office

403 Sarthik 2 Opp Rajpath Club,S G Highway,Ahmedabad,Gujarat,380054

FAX :

Background

Incorporation Year1982

Face Value₹1

Market Lot1

How to buy Vivanza Biosci. shares on nse?

To buy Vivanza Biosci. shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Vivanza Biosci. share price today?

The Vivanza Biosci. shares price on nse is Rs.7.65 today.

What is the market cap of Vivanza Biosci. shares on BSE ?

The company has a market capitalization of Rs.30.60Cr

What is the PE & PB ratio of Vivanza Biosci. shares ?

PE is 95.63 and PB is 6.48

What is the 52 Week High and Low of Vivanza Biosci. shares?

Vivanza Biosci. stock price high: Rs.15.33 Vivanza Biosci. stock price low: Rs.5.7